The new epidemiology of heart failure

被引：8
作者：
Richard J. Rodeheffer
机构：
[1] Mayo Clinic, Rochester, MN 55905
来源：
Current Cardiology Reports | 2003年 / 5卷 / 3期
关键词：
Heart Failure; Diastolic Dysfunction; Ventricular Dysfunction; Brain Natriuretic Peptide; Olmsted County;
D O I：
10.1007/s11886-003-0046-8
中图分类号：
学科分类号：
摘要：
In the past 5 years there has been a significant shift in the focus of heart failure epidemiology research. In the 1960 to 1995 era, persons with overt clinical heart failure were identified by assessment of typical symptoms and signs of heart failure. Recent work has gone beyond symptoms and signs, to include objective echocardiographic measurement of ventricular function. This approach has revealed that most cases of ventricular dysfunction are asymptomatic. It has also underscored the high prevalence of diastolic ventricular dysfunction in the very elderly. Nevertheless, recent data suggest that advances in heart failure therapy may be resulting in improved survival for heart failure patients in the community. Future efforts need to be directed toward early detection of ventricular dysfunction and prevention of symptomatic heart failure. Copyright © 2003 by Current Science Inc.
引用
收藏
页码：181 / 186
页数：5
相关论文
共 31 条
[1]  
McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B., The natural history of congestive heart failure: The Framingham Study, N. Engl. J. Med., 285, pp. 1441-1446, (1971)
[2]  
Rodeheffer R.J., Jacobsen S.L., Gersh B.J., Et al., The incidence and prevalence of congestive heart failure in Rochester, Minnesota, Mayo Clin. Proc., 68, pp. 1143-1150, (1993)
[3]  
Remes J., Reunanen A., Aromaa A., Pyorala K., Incidence of heart failure in eastern Finland: A population-based surveillance study, Eur. Heart J., 13, pp. 588-593, (1992)
[4]  
Schocken D.D., Arrieta M.I., Leaverton P.E., Ross E.A., Prevalence and mortality rate of congestive heart failure in the United States, J. Am. Coll. Cardiol., 20, pp. 301-306, (1992)
[5]  
Congestive heart failure in the United States: A new epidemic, (1996)
[6]  
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N. Engl. J. Med., 327, pp. 685-691, (1992)
[7]  
Pfeffer M.A., Braunwald E., Moye L.A., Et al., Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, N. Engl. J. Med., 327, pp. 669-677, (1992)
[8]  
McDonagh T.A., Morrison C.E., Lawrence A., Et al., Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population, Lancet, 350, pp. 829-833, (1997)
[9]  
Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Et al., Burden of systolic and diastolic ventricular dysfunction in the community, JAMA, 289, pp. 194-202, (2003)
[10]  
Vasan R.S., Benjamin E.J., Levy D., Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective, J. Am. Coll. Cardiol., 26, pp. 1565-1574, (1995)
1234